Polen Capital Zoetis Inc. Transaction History

Polen Capital Management LLC

$39.9 Billion
Q2 2024

A detailed history of Polen Capital (Polen Capital Management LLC) transactions in Zoetis Inc. stock. As of the latest transaction made, Polen Capital Management LLC holds 7,046,051 shares of ZTS stock, worth $1.29 Billion. This represents 3.06% of its overall portfolio holdings.

Number of Shares

7,046,051

Previous 7,005,114 0.58%

Holding current value

$1.29 Billion

Previous $1.19 Billion 3.05%

% of portfolio

3.06%

Previous 2.74%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$145.54 - $178.83 $5.96 Million - $7.32 Million	40,937 Added 0.58%	7,046,051 $1.22 Billion
Q1 2024 May 10, 2024	BUY	$165.67 - $199.94 $337 Million - $407 Million	2,033,370 Added 40.9%	7,005,114 $1.19 Billion
Q4 2023 Feb 13, 2024	SELL	$151.44 - $200.09 $29.1 Million - $38.4 Million	-192,137 Reduced 3.72%	4,971,744 $981 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $39.1 Million - $45.1 Million	-234,037 Reduced 4.34%	5,163,881 $898 Million
Q2 2023 Aug 11, 2023	SELL	$160.94 - $186.23 $21.8 Million - $25.3 Million	-135,756 Reduced 2.45%	5,397,918 $930 Million
Q1 2023 May 11, 2023	SELL	$145.48 - $175.02 $9.94 Million - $12 Million	-68,355 Reduced 1.22%	5,533,674 $921 Million
Q4 2022 Feb 13, 2023	SELL	$131.14 - $157.47 $47.4 Million - $57 Million	-361,819 Reduced 6.07%	5,602,029 $821 Million
Q3 2022 Nov 04, 2022	SELL	$148.29 - $182.55 $4.01 Million - $4.94 Million	-27,043 Reduced 0.45%	5,963,848 $884 Million
Q2 2022 Aug 10, 2022	SELL	$155.97 - $200.09 $112 Million - $143 Million	-715,481 Reduced 10.67%	5,990,891 $1.03 Billion
Q1 2022 May 12, 2022	SELL	$181.39 - $234.03 $565 Million - $729 Million	-3,113,415 Reduced 31.71%	6,706,372 $1.26 Billion
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $45.9 Million - $58.6 Million	237,161 Added 2.47%	9,819,787 $2.4 Billion
Q3 2021 Nov 10, 2021	SELL	$189.29 - $209.69 $440 Million - $488 Million	-2,325,133 Reduced 19.53%	9,582,626 $1.86 Billion
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $49.9 Million - $60.2 Million	320,158 Added 2.76%	11,907,759 $2.22 Billion
Q1 2021 May 12, 2021	BUY	$144.0 - $169.39 $35.2 Million - $41.4 Million	244,701 Added 2.16%	11,587,601 $1.82 Billion
Q4 2020 Feb 11, 2021	BUY	$157.07 - $174.35 $50 Million - $55.5 Million	318,254 Added 2.89%	11,342,900 $1.88 Billion
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $33.5 Million - $40.4 Million	244,464 Added 2.27%	11,024,646 $1.82 Billion
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $113 Million - $144 Million	1,013,095 Added 10.37%	10,780,182 $1.48 Billion
Q1 2020 May 11, 2020	SELL	$92.66 - $144.94 $98.1 Million - $154 Million	-1,059,072 Reduced 9.78%	9,767,087 $1.15 Billion
Q4 2019 Feb 06, 2020	BUY	$116.25 - $133.25 $34.1 Million - $39.1 Million	293,598 Added 2.79%	10,826,159 $1.43 Billion
Q3 2019 Nov 12, 2019	BUY	$112.57 - $128.43 $38.7 Million - $44.2 Million	344,007 Added 3.38%	10,532,561 $1.31 Billion
Q2 2019 Aug 12, 2019	BUY	$97.98 - $114.28 $8.46 Million - $9.87 Million	86,364 Added 0.85%	10,188,554 $1.16 Billion
Q1 2019 May 13, 2019	BUY	$81.56 - $100.67 $44.7 Million - $55.2 Million	548,623 Added 5.74%	10,102,190 $1.02 Billion
Q4 2018 Feb 12, 2019	BUY	$79.28 - $95.27 $14.2 Million - $17 Million	178,893 Added 1.91%	9,553,567 $817 Million
Q3 2018 Nov 13, 2018	BUY	$83.5 - $93.23 $6.65 Million - $7.42 Million	79,594 Added 0.86%	9,374,674 $858 Million
Q2 2018 Aug 09, 2018	BUY	$79.9 - $89.2 $28.1 Million - $31.3 Million	351,447 Added 3.93%	9,295,080 $792 Million
Q1 2018 May 11, 2018	BUY	$71.51 - $84.69 $356 Million - $421 Million	4,974,081 Added 125.31%	8,943,633 $747 Million
Q4 2017 Feb 09, 2018	BUY	$63.24 - $72.8 $251 Million - $289 Million	3,969,552	3,969,552 $286 Million

Others Institutions Holding ZTS

# of Institutions

1,922

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $85.5B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track Polen Capital's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.

Account